Patient preferences for atopic dermatitis treatments: a discrete choice experiment

Background Patients with moderate-to-severe atopic dermatitis (AD) experience skin lesions and intense itch that substantially affect quality of life. Patients have choices among systemic AD treatments that offer varied benefit–risk profiles. Objective Measure patients’ willingness to trade off the...

Full description

Bibliographic Details
Main Authors: Shawn G. Kwatra, Peter Lio, Stephan Weidinger, Brian Calimlim, Barry Ladizinski, Namita Vigna, Willings Botha, Carol Mansfield
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Journal of Dermatological Treatment
Subjects:
Online Access:http://dx.doi.org/10.1080/09546634.2023.2222201
_version_ 1797683474623102976
author Shawn G. Kwatra
Peter Lio
Stephan Weidinger
Brian Calimlim
Barry Ladizinski
Namita Vigna
Willings Botha
Carol Mansfield
author_facet Shawn G. Kwatra
Peter Lio
Stephan Weidinger
Brian Calimlim
Barry Ladizinski
Namita Vigna
Willings Botha
Carol Mansfield
author_sort Shawn G. Kwatra
collection DOAJ
description Background Patients with moderate-to-severe atopic dermatitis (AD) experience skin lesions and intense itch that substantially affect quality of life. Patients have choices among systemic AD treatments that offer varied benefit–risk profiles. Objective Measure patients’ willingness to trade off the risks and benefits of systemic treatments among individuals with a physician-confirmed diagnosis of moderate-to-severe AD. Methods Patients participated in a discrete choice experiment online survey with a series of choices between hypothetical AD treatments defined by six attributes reflecting benefits and risks of treatments (itch reduction, time until noticeable itch reduction, chance of clear or almost clear skin, risk of serious infection, risk of developing acne, and need for prescription topical steroids). Data were analyzed with a random parameters logit model to quantify preferences and the relative importance of attributes for treatment alternatives. Results Respondents (n = 200) placed the highest relative importance on itch reduction, speed of itch reduction, and skin clearance, and were generally willing to accept clinically relevant levels of risk of serious infection and acne in exchange for treatment benefits. Conclusions Patients with moderate-to-severe AD were willing to trade clinically relevant treatment risks for greater or more rapid itch reduction and skin clearance offered by systemic therapies.
first_indexed 2024-03-12T00:14:57Z
format Article
id doaj.art-711ebe21f3c44c08851ac4a3fe3391f6
institution Directory Open Access Journal
issn 0954-6634
1471-1753
language English
last_indexed 2024-03-12T00:14:57Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Dermatological Treatment
spelling doaj.art-711ebe21f3c44c08851ac4a3fe3391f62023-09-15T14:28:53ZengTaylor & Francis GroupJournal of Dermatological Treatment0954-66341471-17532023-12-0134110.1080/09546634.2023.22222012222201Patient preferences for atopic dermatitis treatments: a discrete choice experimentShawn G. Kwatra0Peter Lio1Stephan Weidinger2Brian Calimlim3Barry Ladizinski4Namita Vigna5Willings Botha6Carol Mansfield7Department of Dermatology, Johns Hopkins University School of MedicineDepartments of Dermatology and Pediatrics, Northwestern University Feinberg School of MedicineDepartment of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus KielAbbVie Inc.AbbVie Inc.AbbVie Inc.RTI Health SolutionsRTI Health SolutionsBackground Patients with moderate-to-severe atopic dermatitis (AD) experience skin lesions and intense itch that substantially affect quality of life. Patients have choices among systemic AD treatments that offer varied benefit–risk profiles. Objective Measure patients’ willingness to trade off the risks and benefits of systemic treatments among individuals with a physician-confirmed diagnosis of moderate-to-severe AD. Methods Patients participated in a discrete choice experiment online survey with a series of choices between hypothetical AD treatments defined by six attributes reflecting benefits and risks of treatments (itch reduction, time until noticeable itch reduction, chance of clear or almost clear skin, risk of serious infection, risk of developing acne, and need for prescription topical steroids). Data were analyzed with a random parameters logit model to quantify preferences and the relative importance of attributes for treatment alternatives. Results Respondents (n = 200) placed the highest relative importance on itch reduction, speed of itch reduction, and skin clearance, and were generally willing to accept clinically relevant levels of risk of serious infection and acne in exchange for treatment benefits. Conclusions Patients with moderate-to-severe AD were willing to trade clinically relevant treatment risks for greater or more rapid itch reduction and skin clearance offered by systemic therapies.http://dx.doi.org/10.1080/09546634.2023.2222201atopic dermatitisconditional relative importancediscrete choice experimentpatient preference
spellingShingle Shawn G. Kwatra
Peter Lio
Stephan Weidinger
Brian Calimlim
Barry Ladizinski
Namita Vigna
Willings Botha
Carol Mansfield
Patient preferences for atopic dermatitis treatments: a discrete choice experiment
Journal of Dermatological Treatment
atopic dermatitis
conditional relative importance
discrete choice experiment
patient preference
title Patient preferences for atopic dermatitis treatments: a discrete choice experiment
title_full Patient preferences for atopic dermatitis treatments: a discrete choice experiment
title_fullStr Patient preferences for atopic dermatitis treatments: a discrete choice experiment
title_full_unstemmed Patient preferences for atopic dermatitis treatments: a discrete choice experiment
title_short Patient preferences for atopic dermatitis treatments: a discrete choice experiment
title_sort patient preferences for atopic dermatitis treatments a discrete choice experiment
topic atopic dermatitis
conditional relative importance
discrete choice experiment
patient preference
url http://dx.doi.org/10.1080/09546634.2023.2222201
work_keys_str_mv AT shawngkwatra patientpreferencesforatopicdermatitistreatmentsadiscretechoiceexperiment
AT peterlio patientpreferencesforatopicdermatitistreatmentsadiscretechoiceexperiment
AT stephanweidinger patientpreferencesforatopicdermatitistreatmentsadiscretechoiceexperiment
AT briancalimlim patientpreferencesforatopicdermatitistreatmentsadiscretechoiceexperiment
AT barryladizinski patientpreferencesforatopicdermatitistreatmentsadiscretechoiceexperiment
AT namitavigna patientpreferencesforatopicdermatitistreatmentsadiscretechoiceexperiment
AT willingsbotha patientpreferencesforatopicdermatitistreatmentsadiscretechoiceexperiment
AT carolmansfield patientpreferencesforatopicdermatitistreatmentsadiscretechoiceexperiment